USPTO Examiner NEGIN RUSSELL SCOTT - Art Unit 1686

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19207265REASONING FROM SUPERVISED FINE TUNING OF LANGUAGE FUSION MODELS FOR AI-BASED PROTEIN AND DRUG DESIGNMay 2025September 2025Allow410YesNo
19093126Methods and Systems for Machine-Learning Based Molecule Generation and ScoringMarch 2025January 2026Allow1020YesNo
19072478TREATMENT OF DEPRESSION USING MACHINE LEARNINGMarch 2025October 2025Allow810YesNo
19072452TREATMENT OF DEPRESSION USING MACHINE LEARNINGMarch 2025October 2025Allow810YesNo
19072469TREATMENT OF DEPRESSION USING MACHINE LEARNINGMarch 2025August 2025Allow510NoNo
19031343DRUG DESIGN METHOD BASED ON AUTOREGRESSIVE MODELJanuary 2025August 2025Allow710NoNo
19000940SYNTHON EMBEDDINGS FOR MODELING DNA-ENCODED LIBRARIESDecember 2024March 2026Allow1530YesNo
18980953SYSTEM AND METHOD FOR MAPPING MOLECULES INTO INTERFACESDecember 2024February 2026Allow1420NoNo
18948372GENOMIC MATING METHOD FOR HUAXI CATTLE BASED ON WHOLE GENOME SINGLE NUCLEOTIDE POLYMORPHISM INFORMATION AND APPLICATION THEREOFNovember 2024July 2025Allow810NoNo
18894542INTELLIGENT DESIGN METHOD OF TYPE I DIABETES VACCINESeptember 2024October 2025Abandon1320NoNo
18745375DETECTION OF EARLY-STAGE LUNG CANCER IN SPUTUM USING AUTOMATED FLOW CYTOMETRY AND MACHINE LEARNINGJune 2024September 2025Allow1520NoNo
18719517PROGRAM, INFORMATION PROCESSING DEVICE AND METHODJune 2024December 2025Abandon1840YesNo
18645889COMBINATION THERAPY WITH DIGITAL THERAPEUTICS FOR IMPROVED IMMUNE FUNCTIONApril 2024August 2025Allow1611NoNo
18583948CALCULATION METHOD FOR ANNUAL AVERAGE PROBABILISTIC SEISMIC LOSS OF EXTERNAL SUBSTRUCTURE REINFORCEMENT SYSTEM BASED ON INTERFACIAL SHEAR STRESSESFebruary 2024April 2025Allow1410NoNo
18464705COMPUTER IMPLEMENTED METHOD AND SYSTEM FOR SMALL MOLECULE DRUG DISCOVERYSeptember 2023December 2024Allow1530NoNo
18352112SIGNAL ENCODING AND DECODING IN MULTIPLEXED BIOCHEMICAL ASSAYSJuly 2023July 2024Allow1220YesNo
18327008METHOD AND SYSTEM FOR EVALUATING MELT FRAGMENTATION IN SODIUM-COOLED FAST REACTOR (SFR)May 2023November 2025Allow2920NoNo
18135094PERSONALIZED HEALTH OR BEAUTY SYSTEMApril 2023May 2025Allow2520YesNo
18171802PREDICTIVE TEST FOR PROGNOSIS OF MYELODYSPLASTIC SYNDROME PATIENTS USING MASS SPECTROMETRY OF BLOOD-BASED SAMPLEFebruary 2023August 2025Abandon2910NoNo
18105214USES OF SYSTEMS WITH DEGREES OF FREEDOM POISED BETWEEN FULLY QUANTUM AND FULLY CLASSICAL STATESFebruary 2023August 2025Abandon3010NoNo
18163169MARKERS FOR THE EARLY DETECTION OF COLON CELL PROLIFERATIVE DISORDERSFebruary 2023October 2024Allow2041YesNo
18082487MACHINE LEARNING ENABLED PULSE AND BASE CALLING FOR SEQUENCING DEVICESDecember 2022July 2025Allow3110NoNo
18081526Methods and Systems For Calculating Free Energy Differences Using A Modified Bond Stretch PotentialDecember 2022June 2025Allow3010YesNo
18072716DISCOVERING POPULATION STRUCTURE FROM PATTERNS OF IDENTITY-BY-DESCENTDecember 2022October 2025Abandon3420YesNo
18052681IN SILICO PROCESS FOR SELECTING PROTEIN FORMULATION EXCIPIENTSNovember 2022May 2025Abandon3010NoNo
17971400SYSTEMS AND METHODS FOR ANALYSES OF BIOLOGICAL SAMPLESOctober 2022May 2025Abandon3010NoNo
17951779METAGENOMIC LIBRARY AND NATURAL PRODUCT DISCOVERY PLATFORMSeptember 2022March 2025Abandon3001NoNo
17856497METHOD, SYSTEM, AND COMPUTER PROGRAM PRODUCT FOR DETERMINING A PATIENT RADIATION AND DIAGNOSTIC STUDY SCOREJuly 2022April 2025Allow3410NoNo
17806930ADAPTIVE COMPRESSION AND MODIFICATION OF NANOPORE MEASUREMENT DATAJune 2022August 2025Allow3840YesYes
17824098QUANTITATION AND MODELING OF QUALITY ATTRIBUTES OF THERAPEUTIC MONOCLONAL ANTIBODIESMay 2022June 2025Allow3620NoNo
17744387Detecting False Positive Variant Calls In Next-Generation SequencingMay 2022December 2024Allow3120YesNo
17711390SYSTEM AND METHOD FOR MEASURING LOW-NOISE VIBRATIONAL SPECTRAApril 2022September 2025Allow4240YesNo
17684458STABLE STRUCTURE SEARCH SYSTEM, STABLE STRUCTURE SEARCH METHOD, AND STORAGE MEDIUMMarch 2022March 2026Abandon4810NoNo
17639726METHOD FOR ACQUIRING INTRACELLULAR DETERMINISTIC EVENTS AND ELECTRONIC APPARATUSMarch 2022January 2026Allow4610NoNo
17588221METHOD FOR EVALUATING OF BIOAVAILABILITY OF ORGANIC NITROGEN IN SEWAGEJanuary 2022March 2026Abandon4910NoNo
17568835OPTIMIZED GAMMA-PRIME STRENGTHENED AUSTENITIC TRIP STEEL AND DESIGNING METHODS OF SAMEJanuary 2022July 2024Allow3011NoNo
17620768COMPUTER IMPLEMENTED METHOD TO OPTIMIZE PHYSICAL-CHEMICAL PROPERTIES OF BIOLOGICAL SEQUENCESDecember 2021March 2026Abandon5010NoNo
17551238NON-TRANSITORY COMPUTER-READABLE STORAGE MEDIUM, INFORMATION PROCESSING APPARATUS, AND INFORMATION PROCESSING METHODDecember 2021February 2026Abandon5010NoNo
17539946PROTEIN STRUCTURE INFORMATION PREDICTION METHOD AND APPARATUS, DEVICE, AND STORAGE MEDIUMDecember 2021January 2025Allow3820YesNo
17614059INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD AND INFORMATION PROCESSING PROGRAMNovember 2021December 2025Abandon4910NoNo
17500035METHOD FOR POLYGENIC RISK EVALUATIONOctober 2021February 2026Abandon5210NoNo
17500690Crowd-Sourced Automated Review of Forensic FilesOctober 2021June 2024Allow3211YesNo
17500019HEALTH AUXILIARY SYSTEM FOR EVALUATION OF DISEASE RISKSOctober 2021February 2026Abandon5210NoNo
17475709ADAPTIVE NANOPORE SIGNAL COMPRESSIONSeptember 2021October 2025Allow4921YesYes
17469048METHOD, SYSTEM, APPARATUS FOR DATA STORAGE, DECODING METHOD, AND STORAGE MEDIUMSeptember 2021December 2025Abandon5110NoNo
17410701MULTIMODAL DOMAIN EMBEDDINGS VIA CONTRASTIVE LEARNINGAugust 2021December 2025Allow5210NoNo
17431196MACHINE LEARNING QUANTIFICATION OF TARGET ORGANISMS USING NUCLEIC ACID AMPLIFICATION ASSAYSAugust 2021December 2025Abandon5210YesNo
17430111FEATURE GENERATION BASED ON EIGENFUNCTIONS OF THE SCHRÖDINGER OPERATORAugust 2021November 2025Abandon5210NoNo
17386444Force Field Based Molecular Structure and Conformer GenerationJuly 2021July 2025Allow4710NoNo
17348074QUANTUM MECHANICAL X-RAY CRYSTALLOGRAPHY AND CRYO-EM DIAGNOSTIC FOR MOLECULESJune 2021March 2025Allow4510NoNo
17241724FORMULA AND AXIAL LENGTH SPECIFIC IOL CONSTANT OPTIMIZATIONApril 2021January 2026Abandon5711NoNo
17282624TREATMENT OF DEPRESSION USING MACHINE LEARNINGApril 2021November 2024Allow4420YesNo
17279789METHOD FOR PREDICTING GENOTYPE BY USING SNP DATAMarch 2021June 2025Abandon5010NoNo
17278289HYPOTHESIZING AND VERIFICATION NETWORKS AND METHODS FOR SPECIMEN CLASSIFICATIONMarch 2021August 2025Allow5340NoNo
17248761ADAPTATION OF THE ADVANCED PENG ROBINSON EQUATION OF STATE BASED ON A MOLECULAR STRUCTURE BASIS FOR MODELING THE ASPHALTENE PRECIPITATION OF PETROLEUM FLUIDSFebruary 2021January 2026Allow5951YesNo
17254906HYBRID SIMULATION MODEL FOR SIMULATING MEDICAL PROCEDURESDecember 2020November 2025Allow5950YesNo
17120052METHOD AND SYSTEM FOR IDENTIFYING FASTING AND POSTPRANDIAL PERIODS BASED ON DETECTED EVENTS AND USING THE SAME TO TRAIN A MATHEMATICAL MODELDecember 2020October 2025Allow5831YesNo
17055280DETERMINING EXTERNAL HAIR DAMAGENovember 2020November 2024Allow4830NoNo
16771708METHOD AND DEVICE FOR MONITORING COMPREHENSIVE GROWTH OF POTTED LETTUCENovember 2020July 2024Allow4910NoNo
17069247Coded Trace ReconstructionOctober 2020May 2024Allow4330NoNo
16996263SPECTRUM ANALYSIS APPARATUS, FINE PARTICLE MEASUREMENT APPARATUS, AND METHOD AND PROGRAM FOR SPECTRUM ANALYSIS OR SPECTRUM CHART DISPLAYAugust 2020January 2025Allow5350YesNo
16929591COMPUTATIONAL SCREENING OF CANDIDATE COMPOUNDSJuly 2020October 2025Abandon6020NoYes
16915944RISK CALCULATION FOR EVALUATION OF FETAL ANEUPLOIDYJune 2020August 2024Allow5021YesNo
16905965METHOD AND DEVICE FOR COMPUTING STABLE BINDING STRUCTURE AND COMPUTER-READABLE RECORDING MEDIUM RECORDING PROGRAMJune 2020April 2025Abandon5830NoNo
16879966METHOD FOR GENERATING A DATABASEMay 2020August 2024Allow5160YesYes
16879155METHODS FOR DIAGNOSING A COLORECTAL CANCER (CRC) HEALTH STATE OR CHANGE IN CRC HEALTH STATE, OR FOR DIAGNOSING RISK OF DEVELOPING CRC OR THE PRESENCE OF CRC IN A SUBJECTMay 2020March 2025Abandon5840NoYes
16764406METHOD FOR PERFORMANCE PREDICTION OF GLASS SYSTEMMay 2020October 2025Abandon6021NoNo
16810106PROXY MODELING WORKFLOW AND PROGRAM FOR REACTIVE TRANSPORT MODELINGMarch 2020August 2024Allow5330YesNo
16643814ALLOGENEIC CAR-T PLATFORM USING HLA-MATCHED BANK OF IPSCS, AND RELATED COMPOSITIONS, SYSTEMS, AND METHODSMarch 2020December 2025Abandon6041YesNo
16744488Methods of Lag-Compensation for Analyte Measurements, and Devices Related TheretoJanuary 2020July 2025Allow6060YesNo
16677017Systems and Methods for Detection of AneuploidyNovember 2019September 2023Allow4640NoNo
16548516SYSTEMS AND METHODS FOR DISCOVERY AND ANALYSIS OF MARKERSAugust 2019December 2025Allow6040YesYes
16446354HYBRID QUANTUM-CLASSICAL COMPUTING SYSTEM AND METHODJune 2019September 2024Allow6011NoNo
16414758COMPOSITIONS AND METHODS FOR NUCLEIC ACID-BASED DATA STORAGEMay 2019November 2025Abandon6051YesNo
16308386LINEAR GENOME ASSEMBLY FROM THREE DIMENSIONAL GENOME STRUCTUREDecember 2018January 2025Allow6051YesNo
16148159Real-Time Prediction of Chemical Properties Through Combining Calculated, Structured and Unstructured Data at Large ScaleOctober 2018October 2024Allow6031YesYes
14022390MONITORING BIOMETRIC CHARACTERISTICS OF A USER OF A USER MONITORING APPARATUSSeptember 2013November 2016Allow3830NoNo
13853897SYSTEMS AND METHODS FOR DETECTING THE PRESENCE OF A BIOLOGICAL STATUS USING CLUSTERINGMarch 2013August 2016Allow4030YesNo
13836064Method for predicting whether a cancer patient will not benefit from platinum-based chemotherapy agentsMarch 2013March 2014Allow1221YesNo
13734947PROCESSING OF SKIN CONDUCTANCE SIGNALS TO MITIGATE NOISE AND DETECT SIGNAL FEATURESJanuary 2013May 2018Allow6061YesNo
13636432SYSTEM, METHOD AND COMPUTER-ACCESSIBLE MEDIUM FOR EVALUATING A MALIGNANCY STATUS IN AT-RISK POPULATIONS AND DURING PATIENT TREATMENT MANAGEMENTDecember 2012April 2017Allow5421YesNo
13597385FIELD-BASED SIMILARITY SEARCH SYSTEM AND METHODAugust 2012March 2014Allow1921YesNo
13509347SYSTEMS AND METHODS FOR DETECTING THE PRESENCE OF A BIOLOGICAL STATUS USING PLOTJuly 2012December 2015Allow4320YesNo
13209097BASE SEQUENCE CLUSTER GENERATING SYSTEM, BASE SEQUENCE CLUSTER GENERATING METHOD, PROGRAM FOR PERFORMING CLUSTER GENERATING METHOD, AND COMPUTER READABLE RECORDING MEDIUM ON WHICH PROGRAM IS RECORDED AND SYSTEM FOR PROVIDING BASE SEQUENCE INFORMATIONAugust 2011October 2016Allow6040YesYes
13113256FIELD-BASED SIMILARITY SEARCH SYSTEM AND METHODMay 2011June 2012Allow1320YesNo
13099198MULTIPLEXED ASSAY USING ENCODED SOLID SUPPORT MATRICESMay 2011May 2012Allow1220YesNo
12971375TECHNIQUES FOR DETERMINING THE EFFECTS ON A SYSTEM OF A COMPONENT THAT HAS FOUR STATESDecember 2010January 2012Allow1300YesNo
12855366METHOD, SYSTEM AND APPARATUS TO PREDICT AND/OR RECOGNIZE AND/OR CLASSIFY BIOLOGICAL SEQUENCESAugust 2010April 2014Allow4421YesNo
12802149Device including altered microorganisms, and methods and systems of useMay 2010October 2013Allow4020YesNo
12692729POLYMORPHISM DETECTIONJanuary 2010September 2011Allow2010YesNo
12601592METHOD AND KIT FOR DYNAMIC GENE EXPRESSION MONITORINGNovember 2009February 2016Allow6051YesNo
12607077METHODS FOR ASSEMBLING PANELS OF CANCER CELL LINES FOR USE IN TESTING THE EFFICACY OF ONE OR MORE PHARMACEUTICAL COMPOSITIONSOctober 2009November 2014Allow6020YesNo
12607079GENOMIC CLASSIFICATION OF NON-SMALL CELL LUNG CARCINOMA BASED ON PATTERNS OF GENE COPY NUMBER ALTERATIONSOctober 2009March 2013Allow4120YesNo
12607082GENOMIC CLASSIFICATION OF COLORECTAL CANCER BASED ON PATTERNS OF GENE COPY NUMBER ALTERATIONSOctober 2009March 2013Allow4120YesNo
12607080GENOMIC CLASSIFICATION OF MALIGNANT MELANOMA BASED ON PATTERNS OF GENE COPY NUMBER ALTERATIONSOctober 2009March 2013Allow4121YesNo
12544889FIELD-BASED SIMILARITY SEARCH SYSTEM AND METHODAugust 2009April 2011Allow2021YesNo
12500497SYSTEM, METHOD, DEVICE, AND COMPUTER PROGRAM PRODUCT FOR EXTRACTION, GATHERING, MANIPULATION, AND ANALYSIS OF PEAK DATA FROM AN AUTOMATED SEQUENCERJuly 2009February 2012Allow3210YesNo
12459388DEVICES FOR CONTINUAL MONITORING AND INTRODUCTION OF GASTROINTESTINAL MICROBESJune 2009August 2017Allow6041YesYes
12436844METHOD OF NETWORK-BASED IDENTIFICATION OF MULTICOMPONENT SYNERGY AND COMPOSITIONS FOR USE AS EFFECTIVE COMPONENT OF ANTI-ANGIOGENESIS MEDICINESMay 2009September 2011Allow2911YesNo
12401171METHOD AND SYSTEM FOR TEMPERATURE CORRECTION IN THERMAL MELT ANALYSISMarch 2009September 2016Allow6080NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner NEGIN, RUSSELL SCOTT.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
9
Examiner Affirmed
3
(33.3%)
Examiner Reversed
6
(66.7%)
Reversal Percentile
85.7%
Higher than average

What This Means

With a 66.7% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
26
Allowed After Appeal Filing
10
(38.5%)
Not Allowed After Appeal Filing
16
(61.5%)
Filing Benefit Percentile
63.2%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 38.5% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner NEGIN, RUSSELL SCOTT - Prosecution Strategy Guide

Executive Summary

Examiner NEGIN, RUSSELL SCOTT works in Art Unit 1686 and has examined 91 patent applications in our dataset. With an allowance rate of 81.3%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 52 months.

Allowance Patterns

Examiner NEGIN, RUSSELL SCOTT's allowance rate of 81.3% places them in the 52% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by NEGIN, RUSSELL SCOTT receive 3.19 office actions before reaching final disposition. This places the examiner in the 90% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by NEGIN, RUSSELL SCOTT is 52 months. This places the examiner in the 3% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +40.1% benefit to allowance rate for applications examined by NEGIN, RUSSELL SCOTT. This interview benefit is in the 87% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 23.1% of applications are subsequently allowed. This success rate is in the 31% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 56.0% of cases where such amendments are filed. This entry rate is in the 82% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 70% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 64.0% of appeals filed. This is in the 44% percentile among all examiners. Of these withdrawals, 37.5% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 20.0% are granted (fully or in part). This grant rate is in the 10% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 9.9% of allowed cases (in the 93% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 2.7% of allowed cases (in the 72% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.